TY - JOUR
T1 - Corrigendum: Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor (Frontiers in Cell and Developmental Biology, (2020), 8, (499), 10.3389/fcell.2020.00499)
AU - Barendsen, Rinse W.
AU - Dijkstra, Inge M. E.
AU - Visser, Wouter F.
AU - Alders, Mariëlle
AU - Bliek, Jet
AU - Boelen, Anita
AU - Bouva, Marelle J.
AU - van der Crabben, Saskia N.
AU - Elsinghorst, Ellen
AU - van Gorp, Ankie G. M.
AU - Heijboer, Annemieke C.
AU - Jansen, Mandy
AU - Jaspers, Yorrick R. J.
AU - van Lenthe, Henk
AU - Metgod, Ingrid
AU - Mooij, Christiaan F.
AU - van der Sluijs, Elise H. C.
AU - van Trotsenburg, A. S. Paul
AU - Verschoof-Puite, Rendelien K.
AU - Vaz, Frédéric M.
AU - Waterham, Hans R.
AU - Wijburg, Frits A.
AU - Engelen, Marc
AU - Dekkers, Eugènie
AU - Kemp, Stephan
N1 - Publisher Copyright: Copyright © 2021 Barendsen, Dijkstra, Visser, Alders, Bliek, Boelen, Bouva, van der Crabben, Elsinghorst, van Gorp, Heijboer, Jansen, Jaspers, van Lenthe, Metgod, Mooij, van der Sluijs, van Trotsenburg, Verschoof-Puite, Vaz, Waterham, Wijburg, Engelen, Dekkers and Kemp Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/1/28
Y1 - 2021/1/28
N2 - In the original article, there was a mistake in the legend for Figure 6 as published. Three numbers were not in superscript which changed concentrations and there was an error in dosage. The correct legend appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. Figure 6 | Our patient- and parent-friendly, multidisciplinary, centralized follow-up protocol. 1All follow-up appointments will be scheduled on the same day (Wednesday); 2Before 10:00 AM; 315 µg/kg/dose, max. 125 µg/dose; 410 µg/dL = 276 nmol/L, 18 µg/dL = 497 nmol/L; 510 mg/m2/day in three equal doses (3 times per day 33.3% of the total daily dose); when older than 6 months: 50% early in the morning, and 25% early in the afternoon and evening. Adrenal surveillance protocol adapted and modified from Regelmann et al. (2018). Abbreviations: ACTH, adrenocorticotropic hormone; K, potassium;Na, sodium; PRA, plasma renin activity; Q&A, questions & answers.
AB - In the original article, there was a mistake in the legend for Figure 6 as published. Three numbers were not in superscript which changed concentrations and there was an error in dosage. The correct legend appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. Figure 6 | Our patient- and parent-friendly, multidisciplinary, centralized follow-up protocol. 1All follow-up appointments will be scheduled on the same day (Wednesday); 2Before 10:00 AM; 315 µg/kg/dose, max. 125 µg/dose; 410 µg/dL = 276 nmol/L, 18 µg/dL = 497 nmol/L; 510 mg/m2/day in three equal doses (3 times per day 33.3% of the total daily dose); when older than 6 months: 50% early in the morning, and 25% early in the afternoon and evening. Adrenal surveillance protocol adapted and modified from Regelmann et al. (2018). Abbreviations: ACTH, adrenocorticotropic hormone; K, potassium;Na, sodium; PRA, plasma renin activity; Q&A, questions & answers.
KW - X chromosome
KW - adrenoleukodystrophy
KW - dried bloodspots
KW - gender
KW - heel prick
KW - neonatal
KW - newborn screening
KW - peroxisomes
UR - http://www.scopus.com/inward/record.url?scp=85101053804&partnerID=8YFLogxK
U2 - https://doi.org/10.3389/fcell.2021.631655
DO - https://doi.org/10.3389/fcell.2021.631655
M3 - Comment/Letter to the editor
C2 - 33585488
SN - 2296-634X
VL - 9
JO - Frontiers in cell and developmental biology
JF - Frontiers in cell and developmental biology
M1 - 631655
ER -